Exhibit B FORM OF LOCK-UP AGREEMENTLock-Up Agreement • July 3rd, 2018 • New Leaf Ventures III, L.P. • Pharmaceutical preparations • New York
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 21st, 2019 • New Leaf Ventures III, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of securities of the Issuer.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 11th, 2021 • New Leaf Ventures III, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Passage Bio, Inc.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • October 11th, 2017 • New Leaf Ventures III, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Parent Lock-Up AgreementLock-Up Agreement • March 25th, 2019 • New Leaf Ventures III, L.P. • Pharmaceutical preparations • Delaware
Exhibit E AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • February 13th, 2020 • New Leaf Ventures III, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 11th, 2022 • New Leaf Ventures III, L.P. • Pharmaceutical preparations
The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge that each is responsible for the timely filing of such statement on Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning him, her or it contained therein, but shall not be responsible for the completeness or accuracy of the information concerning the others of the undersigned, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate or incomplete. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 13th, 2020 • New Leaf Ventures III, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of securities of the Issuer.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint Filing of Schedule 13g • October 10th, 2018 • New Leaf Ventures III, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Arvinas, Inc.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • July 3rd, 2018 • New Leaf Ventures III, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint Filing of Schedule 13g • February 13th, 2019 • New Leaf Ventures III, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Unum Therapeutics Inc.
